Milestone Group adds McKesson Corporation (MCK) to its portfolio

McKesson Corporation (MCK) : Milestone Group added new position in McKesson Corporation during the most recent quarter end. The investment management firm now holds 1,574 shares of McKesson Corporation which is valued at $307,308 , the company said in a statement filed on Aug 10, 2016 with the SEC.McKesson Corporation makes up approximately 0.05% of Milestone Group’s portfolio.

Other Hedge Funds, Including , First Mercantile Trust Co boosted its stake in MCK in the latest quarter, The investment management firm added 3,000 additional shares and now holds a total of 8,800 shares of McKesson Corporation which is valued at $1,718,112. McKesson Corporation makes up approx 0.20% of First Mercantile Trust Co’s portfolio.Tci Wealth Advisors reduced its stake in MCK by selling 85 shares or 4.63% in the most recent quarter. The Hedge Fund company now holds 1,751 shares of MCK which is valued at $344,282. McKesson Corporation makes up approx 0.18% of Tci Wealth Advisors’s portfolio.Exane Derivatives reduced its stake in MCK by selling 8 shares or 1.86% in the most recent quarter. The Hedge Fund company now holds 422 shares of MCK which is valued at $82,349. McKesson Corporation makes up approx 0.01% of Exane Derivatives’s portfolio.Highland Capital Management reduced its stake in MCK by selling 10 shares or 0.14% in the most recent quarter. The Hedge Fund company now holds 7,223 shares of MCK which is valued at $1,433,332. McKesson Corporation makes up approx 0.12% of Highland Capital Management’s portfolio.

McKesson Corporation closed down -0.58 points or -0.30% at $193.85 with 8,01,089 shares getting traded on Friday. Post opening the session at $193.78, the shares hit an intraday low of $192.97 and an intraday high of $194.77 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.

Investors should note that on Jul 26, 2016, McKesson Corporation announced a cash dividend of $0.2800. The company’s management has announced Aug 30, 2016 as the ex-dividend date and fixed the record date on Sep 1, 2016. The payable date has been fixed on Oct 3, 2016.

Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 197 from a previous price target of $174 .Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *